Epilepsy — United States (General Adult population)
Adult patients with epilepsy receiving VNS therapy.
Consider improvement in mood as an additional benefit of VNS therapy.
Patients with epilepsy undergoing VNS therapy over multiple years.
Consider that VNS may have improved efficacy over time, with a 7% increase in ≥50% seizure frequency reduction rates from 1 to 5 years postimplantation.
Patients with epilepsy undergoing VNS therapy.
Counsel patients that VNS magnet activation may be associated with seizure abortion when used at the time of seizure auras.
Counsel patients that seizure abortion with magnet use may be associated with overall response to VNS treatment.
Optimal VNS settings are still unknown; evidence is insufficient to recommend standard stimulation (30 seconds on, 300 seconds off) vs rapid stimulation (7 seconds on, 30 seconds off) to reduce seizure occurrence.
Related Clinical Tools
